公开(公告)号：US20220143231A1

公开(公告)日：2022-05-12

申请号：US17522144

申请日：2021-11-09

Applicant: Janssen Biotech, Inc.

Inventor： Rhys Salter ,  Vadim Y. Dudkin ,  Fengbin Song ,  Wei Zhang ,  Shalom Goldberg ,  John Keith

IPC: A61K51/10 ,  A61K47/55 ,  A61K51/04 ,  A61K47/68 ,  A61K47/54

Abstract: The present invention is directed to compounds and pharmaceutically acceptable salts thereof, immunoconjugates, radioimmunoconjugates thereof, pharmaceutical compositions containing said compounds and immunoconjugates, radioimmunoconjugates thereof, and the use of said compounds and immunoconjugates, radioimmunoconjugates thereof, in the treatment of neuroplastic diseases or disorders.

公开(公告)号：US20240238461A1

公开(公告)日：2024-07-18

申请号：US18516304

申请日：2023-11-21

Applicant: Janssen Biotech, Inc.

Inventor： Rhys Salter ,  Vadim Y. Dudkin ,  Fengbin Song ,  Wei Zhang ,  Shalom Goldberg ,  John Keith

IPC: A61K51/10 ,  A61K47/54 ,  A61K47/55 ,  A61K47/68 ,  A61K51/04

CPC classification number: A61K51/1096 ,  A61K47/545 ,  A61K47/55 ,  A61K47/6803 ,  A61K51/0497

Abstract: The present invention is directed to compounds and pharmaceutically acceptable salts thereof, immunoconjugates, radioimmunoconjugates thereof, pharmaceutical compositions containing said compounds and immunoconjugates, radioimmunoconjugates thereof, and the use of said compounds and immunoconjugates, radioimmunoconjugates thereof, in the treatment of neuroplastic diseases or disorders.